Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
HilleVax Inc has a consensus price target of $2.33 based on the ratings of 5 analysts. The high is $3 issued by Stifel on July 9, 2024. The low is $2 issued by HC Wainwright & Co. on March 31, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Leerink Partners on March 31, 2025, August 12, 2024, and July 9, 2024, respectively. With an average price target of $2 between HC Wainwright & Co., HC Wainwright & Co., and Leerink Partners, there's an implied 8.61% upside for HilleVax Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/31/2025 | Buy Now | 8.61% | HC Wainwright & Co. | Matthew Caufield52% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
08/12/2024 | Buy Now | 8.61% | HC Wainwright & Co. | Matthew Caufield52% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
07/09/2024 | Buy Now | 8.61% | Leerink Partners | David Risinger72% | $28 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
07/09/2024 | Buy Now | 62.91% | Stifel | Stephen Willey48% | $34 → $3 | Downgrade | Buy → Hold | Get Alert |
07/09/2024 | Buy Now | — | HC Wainwright & Co. | Matthew Caufield52% | — | Downgrade | Buy → Neutral | Get Alert |
07/08/2024 | Buy Now | — | JP Morgan | Eric Joseph42% | — | Downgrade | Overweight → Neutral | Get Alert |
07/08/2024 | Buy Now | — | Guggenheim | Seamus Fernandez60% | — | Downgrade | Buy → Neutral | Get Alert |
05/15/2024 | Buy Now | 1203.29% | JP Morgan | Eric Joseph42% | $21 → $24 | Maintains | Overweight | Get Alert |
05/10/2024 | Buy Now | 1420.5% | HC Wainwright & Co. | Matthew Caufield52% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | Buy Now | 1420.5% | HC Wainwright & Co. | Matthew Caufield52% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
12/13/2023 | Buy Now | 1420.5% | HC Wainwright & Co. | Matthew Caufield52% | → $28 | Initiates | → Buy | Get Alert |
11/15/2023 | Buy Now | 1746.32% | Guggenheim | Seamus Fernandez60% | $38 → $34 | Maintains | Buy | Get Alert |
11/10/2023 | Buy Now | 1529.11% | Stifel | Stephen Willey48% | $35 → $30 | Maintains | Buy | Get Alert |
05/16/2023 | Buy Now | 1094.68% | JP Morgan | Eric Joseph42% | $23 → $22 | Maintains | Overweight | Get Alert |
The latest price target for HilleVax (NASDAQ:HLVX) was reported by HC Wainwright & Co. on March 31, 2025. The analyst firm set a price target for $2.00 expecting HLVX to rise to within 12 months (a possible 8.61% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for HilleVax (NASDAQ:HLVX) was provided by HC Wainwright & Co., and HilleVax reiterated their neutral rating.
There is no last upgrade for HilleVax
The last downgrade for HilleVax Inc happened on July 9, 2024 when Leerink Partners changed their price target from $28 to $2 for HilleVax Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HilleVax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HilleVax was filed on March 31, 2025 so you should expect the next rating to be made available sometime around March 31, 2026.
While ratings are subjective and will change, the latest HilleVax (HLVX) rating was a reiterated with a price target of $2.00 to $2.00. The current price HilleVax (HLVX) is trading at is $1.84, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.